IPOS - Haoxi Health Technology Limited Announces Pricing of Its Initial Public Offering | Benzinga
BEIJING, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced the pricing of its initial public offering (the "Offering") of 2,400,000 Class A ordinary shares (the "Ordinary Shares") at a public offering price of $4.00 per share ("Public Offering Price") for total gross proceeds of $9,600,000, before deducting underwriting discounts and other offering expenses. The Ordinary Shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on January 26, 2024, under the ticker symbol "HAO".
The Offering is being conducted on a firm commitment basis. The Company has granted EF Hutton LLC ("EF Hutton"), the underwriter, an option, within 45 days from the closing date of the Offering, to purchase up to an additional 360,000 Ordinary Shares at the Public Offering Price, less underwriting discounts, to cover the over-allotment option.
The Offering is expected to close on or about January 30, 2024, subject to the satisfaction of customary closing conditions.
EF Hutton is acting as the sole bookrunner for the Offering. Hunter Taubman Fischer & Li LLC is acting as U.S. counsel to the Company, and Pryor Cashman LLP is acting as U.S. counsel to EF Hutton, in connection with the Offering.
The Company intends to use the proceeds from this Offering for 1) working capital and general corporate purposes; 2) acquiring or investing in technologies, solutions, or businesses; and 3) hiring experienced employees.
The registration statement on Form ...